Source link : https://newshealth.biz/health-news/fda-okays-new-indications-for-once-weekly-growth-hormone/
Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-okays-new-indications-once-weekly-growth-hormone-2026a10006dl?src=rss Author : Publish date : 2026-03-02 11:06:00 Copyright for syndicated content belongs to the linked Source.
The post FDA Okays New Indications for Once-Weekly Growth Hormone first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-02 11:06:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8